HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhengqi Lu Selected Research

Cystatin C

1/2022Cerebrospinal fluid cystatin C levels in patients with anti-NMDAR encephalitis and other neurological diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhengqi Lu Research Topics

Disease

22Neuromyelitis Optica (Devic's Disease)
01/2022 - 04/2011
15Stroke (Strokes)
04/2021 - 01/2013
14Multiple Sclerosis
01/2022 - 02/2008
11Ischemic Stroke
04/2021 - 06/2015
11Autoimmune Diseases (Autoimmune Disease)
01/2020 - 02/2008
9Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2022 - 01/2017
9Demyelinating Diseases (Demyelinating Disease)
01/2019 - 01/2009
7Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2019 - 02/2008
5Inflammation (Inflammations)
11/2019 - 01/2009
4Infarction (Infarctions)
01/2021 - 01/2017
4Encephalitis (Encephalitis, Rasmussen)
07/2020 - 01/2018
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2019 - 06/2015
3Cerebral Small Vessel Diseases
01/2020 - 01/2020
3Brain Ischemia (Cerebral Ischemia)
11/2019 - 06/2015
3Parkinson Disease (Parkinson's Disease)
01/2019 - 11/2017
3Atherosclerosis
01/2018 - 07/2015
3Ischemia
01/2017 - 06/2015
2Meningeal Tuberculosis (Tuberculous Meningitis)
01/2022 - 01/2013
2Meningitis
01/2022 - 01/2011
2Neoplasms (Cancer)
01/2021 - 02/2017
2Cognitive Dysfunction
01/2021 - 01/2020
2Central Nervous System Diseases (CNS Diseases)
07/2020 - 01/2020
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2020 - 01/2020
2Neuroinflammatory Diseases
01/2020 - 01/2014
2Dysbiosis
10/2019 - 01/2019
2Encephalomyelitis (Myeloencephalitis)
01/2019 - 02/2013
2Myelitis
01/2018 - 02/2014
2Optic Neuritis (Retrobulbar Neuritis)
02/2014 - 01/2012
2Tuberculosis (Tuberculoses)
01/2013 - 01/2011
2Brain Stem Infarctions (Weber Syndrome)
01/2013 - 06/2012
1Guillain-Barre Syndrome
01/2022
1Spinal Cord Injuries (Spinal Cord Injury)
01/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Schizophrenia (Dementia Praecox)
01/2022
1Meningoencephalitis
01/2022
1Epilepsy (Aura)
01/2022
1Bacterial Meningitis
01/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022
1Adenocarcinoma
01/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2020
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2020
1Sleep Deprivation
01/2020
1Insulin Resistance
01/2020
1Ganglion Cysts (Ganglion)
01/2020

Drug/Important Bio-Agent (IBA)

13AntibodiesIBA
01/2021 - 01/2011
7N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2020 - 01/2017
5CytokinesIBA
01/2020 - 06/2015
5Immunoglobulin G (IgG)IBA
01/2018 - 01/2012
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2012
4AutoantibodiesIBA
07/2020 - 08/2014
4Myelin-Oligodendrocyte GlycoproteinIBA
01/2020 - 04/2017
4hydroxide ionIBA
01/2019 - 10/2016
4C-Reactive ProteinIBA
11/2017 - 01/2013
3AntigensIBA
01/2021 - 02/2008
3Therapeutic UsesIBA
01/2021 - 02/2008
3Glucose (Dextrose)FDA LinkGeneric
01/2020 - 07/2017
3Interleukin-9 (Interleukin 9)IBA
01/2019 - 06/2015
3urinastatin (MR 20)IBA
02/2015 - 11/2011
2SaltsIBA
04/2021 - 01/2020
2Messenger RNA (mRNA)IBA
01/2020 - 01/2016
2Apolipoproteins E (ApoE)IBA
01/2020 - 01/2018
2Interleukin-10 (Interleukin 10)IBA
01/2020 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019 - 01/2019
2Volatile Fatty AcidsIBA
10/2019 - 01/2019
225-hydroxyvitamin DIBA
01/2019 - 01/2018
2HomocysteineIBA
01/2019 - 01/2013
2ChemokinesIBA
01/2018 - 01/2016
2Proteins (Proteins, Gene)FDA Link
11/2017 - 01/2013
2Uric Acid (Urate)IBA
09/2017 - 01/2017
2InterleukinsIBA
07/2017 - 08/2013
2Prion ProteinsIBA
05/2017 - 01/2017
2MicroRNAs (MicroRNA)IBA
05/2017 - 02/2015
2Azathioprine (Imuran)FDA LinkGeneric
04/2017 - 07/2015
2Apolipoproteins B (ApoB)IBA
03/2017 - 01/2017
2LipidsIBA
01/2017 - 01/2017
2danaparoid (Orgaran)FDA Link
09/2016 - 03/2014
2Neuroprotective AgentsIBA
01/2014 - 01/2014
2Hemoglobins (Hemoglobin)IBA
01/2013 - 06/2012
2Aquaporin 4IBA
01/2012 - 04/2011
2Peptides (Polypeptides)IBA
01/2009 - 02/2008
1Cystatin CIBA
01/2022
1SodiumIBA
04/2021
1Aquaporins (Water Channels)IBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1Caspase 1 (ICE Protease)IBA
01/2021
1EnzymesIBA
01/2021
1InflammasomesIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Trazodone (Trittico)FDA LinkGeneric
01/2020
1Triglycerides (Triacylglycerol)IBA
01/2020
1Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2020
1Retinaldehyde (Retinal)IBA
01/2020

Therapy/Procedure

6Therapeutics
01/2022 - 01/2016
5Aftercare (After-Treatment)
01/2021 - 06/2016
1Cognitive Training
01/2021
1Transcranial Magnetic Stimulation
01/2021